Accumulating evidence suggests that p62 is an important oncoprotein 45-47, particularly in pancreatic cancer, where p62 promotes tumor progression by stabilizing NRF2, which modulates the stress response and malignant phenotype 46. This evidence concerns the gene NFE2L2 and familial pancreatic carcinoma.